- Home
- TSHA vs MLAC Comparison
TSHA vs MLAC Comparison
Compare TSHA & MLAC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TSHA
- MLAC
- Stock Information
- Founded
- TSHA 2019
- MLAC 2024
- Country
- TSHA United States
- MLAC United States
- Employees
- TSHA N/A
- MLAC N/A
- Industry
- TSHA Biotechnology: Pharmaceutical Preparations
- MLAC
- Sector
- TSHA Health Care
- MLAC
- Exchange
- TSHA Nasdaq
- MLAC NYSE
- Market Cap
- TSHA 356.7M
- MLAC 309.8M
- IPO Year
- TSHA 2020
- MLAC 2024
- Fundamental
- Price
- TSHA $1.38
- MLAC $10.05
- Analyst Decision
- TSHA Strong Buy
- MLAC
- Analyst Count
- TSHA 8
- MLAC 0
- Target Price
- TSHA $6.63
- MLAC N/A
- AVG Volume (30 Days)
- TSHA 1.6M
- MLAC 45.3K
- Earning Date
- TSHA 05-13-2025
- MLAC 01-01-0001
- Dividend Yield
- TSHA N/A
- MLAC N/A
- EPS Growth
- TSHA N/A
- MLAC N/A
- EPS
- TSHA N/A
- MLAC N/A
- Revenue
- TSHA $8,333,000.00
- MLAC N/A
- Revenue This Year
- TSHA N/A
- MLAC N/A
- Revenue Next Year
- TSHA N/A
- MLAC N/A
- P/E Ratio
- TSHA N/A
- MLAC $410.04
- Revenue Growth
- TSHA N/A
- MLAC N/A
- 52 Week Low
- TSHA $1.17
- MLAC $9.94
- 52 Week High
- TSHA $4.32
- MLAC $10.17
- Technical
- Relative Strength Index (RSI)
- TSHA 34.93
- MLAC N/A
- Support Level
- TSHA $1.59
- MLAC N/A
- Resistance Level
- TSHA $1.87
- MLAC N/A
- Average True Range (ATR)
- TSHA 0.15
- MLAC 0.00
- MACD
- TSHA -0.01
- MLAC 0.00
- Stochastic Oscillator
- TSHA 24.36
- MLAC 0.00
About TSHA Taysha Gene Therapies Inc.
Taysha Gene Therapies Inc is a patient-centric gene therapy company to eradicate monogenic CNS disease. It is focused on developing and commercializing AAV-based gene therapies for the treatment of monogenic diseases of the CNS in both rare and large patient populations. The company develops and commercializes transformative gene therapy treatments. Its product pipeline includes, TSHA-102 which is a is a self-complementary intrathecally delivered AAV9 gene transfer therapy in clinical evaluation for Rett syndrome.
About MLAC MOUNTAIN LAKE ACQUISITION CORP
Mountain Lake Acquisition Corp is a blank check company.